Chemicals Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Chemicals Press Releases.

Press releases published on March 28, 2026

Mar. 28, 2026

Keep It Blue Pool Service Introduces Green to Clean Restoration for Spring Hill, FL Pool Owners

Indeterminate EIN Presswire

Mar. 28, 2026

Global PPO Resins Market Forecast: Asia-Pacific Electronics Boom Fuels Growth Led by SABIC & Asahi Kasei Corporation

Indeterminate EIN Presswire

Mar. 28, 2026

CO₂-Derived Chemicals Market Outlook: Europe Leads Carbon Utilization Revolution with Covestro AG

Indeterminate EIN Presswire

Mar. 28, 2026

Phosphorus Trichloride Market to Reach $3.8 Bn by 2035 with BASF, LANXESS, and Arkema Driving Specialty Chemical Growth

Indeterminate EIN Presswire

Mar. 28, 2026

Gelatin Trick 2026 Warning: Does the Viral Gelatin Trick Recipe Actually Work? — Pink Gelatin Trick, Ice Gelatin Trick, Bariatric Jello, and Why Consumers Are Choosing Gelatine Sculpt Instead (New Investigation)

Indeterminate GlobeNewswire

Mar. 28, 2026

Steel Power Male Enhancement Claims Evaluated: Complete SteelPower Performance Report for Men

Indeterminate GlobeNewswire

Mar. 28, 2026

MoonLake announces Week 40 Results from its Phase 3 Clinical Trials of Sonelokimab in Hidradenitis Suppurativa at the 2026 AAD Annual Meeting

Indeterminate GlobeNewswire

Mar. 28, 2026

Biogen Announces Second Positive Phase 2 Litifilimab Trial in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting, Showing a Significant Reduction in Skin Disease Activity

Indeterminate GlobeNewswire

Mar. 28, 2026

New England Journal of Medicine Publishes Positive Phase 3 VALOR Trial Results of Brepocitinib in Dermatomyositis

Indeterminate GlobeNewswire

Mar. 28, 2026

Gelatide Drops Under Investigation: Full Gelatide-1 Consumer Report Reveals Shocking Hidden Risks & Fake Gelatin Trick Recipe

Indeterminate GlobeNewswire

Mar. 28, 2026

Alumis’ Envudeucitinib Delivers Early and Robust Improvements in Skin Clearance, Quality of Life and Psoriasis Symptoms in Two Phase 3 Trials, Underscoring Its Potential as a Leading Oral Therapy for Plaque Psoriasis

Indeterminate GlobeNewswire

Mar. 28, 2026

SonusZen Claims Evaluated: Testing the Legitimacy of Sonus Zen Formulation for Hearing Support

Indeterminate GlobeNewswire

Mar. 28, 2026

Communiqué de presse : AAD : Sanofi présente de nouveaux résultats de phase 3 pour l'amlitelimab dans la dermatite atopique lors d'une session de dernière minute

Indeterminate GlobeNewswire

Mar. 28, 2026

Arcutis Presents New Phase 2 Results in Infants with Atopic Dermatitis in Late-Breaking Session Today at the 2026 American Academy of Dermatology Annual Meeting

Indeterminate GlobeNewswire

Mar. 28, 2026

Press Release: AAD: new results from Sanofi's amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session

Indeterminate GlobeNewswire

Mar. 28, 2026

Kymera Therapeutics Presents KT-621 BroADen Data in Late-Breaking Research Session at the American Academy of Dermatology (AAD) Annual Meeting

Indeterminate GlobeNewswire

Mar. 28, 2026

CODE27 Secures Over $10 Million in Funding to Build Immersive Interactive Character Companion Hardware

Indeterminate GlobeNewswire

Mar. 28, 2026

TxFlow L1 Mainnet Launch Marks a New Phase for Multi-Application On-Chain Finance

Indeterminate GlobeNewswire

Mar. 28, 2026

Rocket Lab Successfully Launches 85th Mission and First Dedicated Launch for European Space Agency

Indeterminate GlobeNewswire

Mar. 28, 2026

DeerValley Redefines Bathroom Hygiene with Launch of Premium V3 Smart Toilet Series

Indeterminate GlobeNewswire